Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

Gudlaug Olafsdottir; Sif M. Bukhave; Georges Kalligeros; Hallgreen CE; Marie Louise (Marieke) De Bruin

Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

Gudlaug Olafsdottir, Sif M. Bukhave, Georges Kalligeros, Hallgreen CE, Marie Louise (Marieke) De Bruin

Pharmacoepi & Clinical Pharmacology
Centre for Pharmaceutical Policy and Regulation
Pharmacoepidemiology and Clinical Pharmacology

Research output: Contribution to conference › Abstract › Academic

Original language	English
Publication status	Published - Aug 2018

Cite this

TY - CONF

T1 - Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

AU - Olafsdottir, Gudlaug

AU - Bukhave, Sif M.

AU - Kalligeros, Georges

AU - CE, Hallgreen

AU - Bruin, Marie Louise (Marieke) De

PY - 2018/8

Y1 - 2018/8

UR - https://curis.ku.dk/portal/en/publications/impact-of-the-2012-pharmacovigilance-legislation-on-the-harmonisation-of-dhpcs-in-the-eu(bd096542-110c-4141-9cbe-3eb3ec25404e).html

M3 - Abstract

ER -

Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU

Other files and links

Cite this